Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
08/2005
08/18/2005US20050182061 Phthalimide compounds useful as protein kinase inhibitors
08/18/2005US20050182055 5-Chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide formed by reacting 4-{4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}-morpholin-3-one hydrochloride with 5-chlorothiophene-2-carbonyl chloride
08/18/2005US20050182048 Paraciticides for use on or in animals, against insects, arachnids and nematodes; 1-(haloalkyl-substituted aryl)-3-cyano-4-alkylthio-5-(alkylthioalkylamino)pyrazoles or S-oxides thereof
08/18/2005US20050179032 Octupolar molecules used as organic semiconductors
08/18/2005US20050179013 Hyperpolarizable organic chromophores
08/18/2005CA2554878A1 Bisarylurea derivatives
08/18/2005CA2554796A1 Modulators of atp-binding cassette transporters
08/17/2005EP1564210A1 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors
08/17/2005EP1562939A1 Carboxamides
08/17/2005EP1562933A2 Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders
08/17/2005EP1562931A2 Anti-infective biaryl compounds
08/17/2005EP1562928A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
08/17/2005EP1562911A1 Compositions useful as inhibitors of jak and other protein kinases
08/17/2005EP1562899A2 N-(indole-2-carbonyl)amides as anti-diabetic agents
08/17/2005EP1562895A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/17/2005EP1562595A1 Diaryl ethers as opioid receptor antagonists
08/17/2005EP1499594B1 Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles
08/17/2005EP1282418B1 Use of pyrazole derivatives for treating infertility
08/17/2005EP1266887B1 Indenoindoline derivatives, their process of preparation and pharmaceutical compositions containing them
08/17/2005EP1202945B1 Methods for preparing perfluorinated [18 f]-radiolabelled nitroimidazole derivatives for cellular hypoxia detection
08/17/2005CN1656089A Phenyl-thiophene type vitamin D receptor modulators
08/17/2005CN1656087A Therapeutic ion channel blocking agents and methods of use thereof
08/17/2005CN1656079A Pyrazole compounds and pharmaceutical compositions comprising the compound
08/17/2005CN1656078A Aminoindazole derivatives as protein kinase inhibitor
08/17/2005CN1656072A Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
08/17/2005CN1656071A New piperidine derivative
08/17/2005CN1656069A 1-(aminoalkyl)-3-sulfonylindole and-indazole derivatives as 5-hydroxytryptamine-6 ligands
08/17/2005CN1655785A N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders
08/17/2005CN1655779A Substituted benzazoles and methods of their use as inhibitors of Raf kinase
08/17/2005CN1654459A Substituted aminosalicylic acid amides with fungicidal effect and intermediate products for production thereof
08/17/2005CN1215069C Sulfonamicles and derivatives thereof that moulate the activity of endothelin
08/17/2005CN1215067C 哒嗪酮醛糖还原酶抑制剂 Pyridazinone aldose reductase inhibitors
08/17/2005CN1215061C Process for preparing anticancer compound, and intermediate
08/17/2005CN1215059C Novel heterocyclic compounds and salts thereof and medicinal use of same
08/16/2005US6930107 treating obesity, overweight condition, hyperlipidemia, thyroid disease, hypothyroidism, thyroid cancer and related disorders
08/16/2005US6930104 beta -amyloid precursor protein secretory stimulators; treating neurodegenerative disorders; n-carbamoyl- quinoxaline or quinoline derivatives
08/16/2005CA2323707C New substances derived from benzothiophenes, benzofurans and indolics, processes for preparing them and pharmaceutical compounds containing them
08/11/2005WO2005073216A2 Hcv ns-3 serine protease inhibitors
08/11/2005WO2005073206A1 Selective estrogen receptor modulators
08/11/2005WO2005073205A1 Selective estrogen receptor modulators
08/11/2005WO2005073198A1 Heterocyclic sulfonamide inhibitors of beta amyloid production containing an azole
08/11/2005WO2005073197A1 Derivatives of n-` (1,5-diphenyl-1h-pyrazol-3-yl) sulphonamide with cb1 receptor affinity
08/11/2005WO2005073196A1 OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCING α-AMINO ACID AND DERIVATIVE THEREOF WITH THE SAME
08/11/2005WO2005073195A2 Hcv ns-3 serine protease inhibitors
08/11/2005WO2005072733A1 Dyarylurea compounds as chk-1 inhibitors
08/11/2005WO2005072681A2 Vanilloid receptor ligands and their use in treatments of inflammatory and neurotic pain.
08/11/2005WO2005053663A3 Norepinephrine reuptake inhibitors useful for treatment of cognitive failure
08/11/2005WO2005007635A3 Combretastatin derivatives with cytotoxic action
08/11/2005US20050177011 ethylene, chlorine, catalyst; solvent is ECD; prevents formation of an interface that promotes side reactions; undissolved gases removed by centrifugal separator
08/11/2005US20050176964 Nicotinamide derivatives useful as p38 inhibitors
08/11/2005US20050176958 Rhodium and iridium complexes
08/11/2005US20050176813 Modulating the potassium ion channel activity of T-cells; autoimmune and inflammatory diseases such as multiple sclerosis, rheumatoid arthritis or transplant rejection; synthesis by reaction of an acetophenone such as khellinone with an aryl aldehyde
08/11/2005US20050176799 drugs such as 1-Benzyl-3-(2-furyl)-5-trifluoromethylpyrazole, capable of modulating biosynthesis of cyclic guanosine monophosphate, used for therapy and prophylaxis of cardiovascular disorders such as hypertension, angina pectoris, cardiac insufficiency, thrombosis or atherosclerosis
08/11/2005US20050176780 2,5-disubstituted 3-mercaptopentanoic acid
08/11/2005US20050176775 Substituted pyridinones
08/11/2005US20050176771 4-fluoro-1-({[1-(methanesulfonyl)piperidin-4-yl]amino}acetyl)pyrrolidine-2-carbonitrile; insulin-dependent diabetes (type 1 diabetes), non insulin-dependent diabetes (type 2 diabetes), insulin-resistant disorders, obesity; dipeptidyl peptidase IV-inhibiting activity
08/11/2005US20050176767 Pyridine carboxamide and methods for inhibiting HIV integrase
08/11/2005US20050176765 For therapy of glaucoma, dementia such as Alzheimer's disease and vascular dementia, depression, attention deficit disorder, sleep disorder, schizophrenia, pain, ischemia; -[1-[1-(3-Thienoyl)piperidin-4-yl]piperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one
08/11/2005US20050176762 Tachykinin receptor subtypes NK3 and NK2 (NK neurokinin); various diseases including respiratory system disorders, autoimmune disorders, psychological disorders, skin disorders
08/11/2005US20050176758 2-(hydroxy or methoxymethoxy)-4-(carboxy or alkoxycarbonyl)-5-(fluoro or hydrogen)-7-oxabicyclo(4.1.0)hept-3-ene chemical intermediates to neuraminidase inhibitors
08/11/2005US20050176733 Chk-1 inhibitors
08/11/2005US20050176719 An enzyme inhibitors of cyclin-dependent kinases, antitumor agents; chemical intermediate synthesis
08/11/2005US20050176712 Integrin expression inhibitor
08/11/2005US20050176709 Selective NPY (Y5) antagonists
08/11/2005US20050176708 Piperidine derivatives useful as modulators of chemokine receptor activity
08/11/2005US20050176705 5-Chloro-1-(3,5-dichloro-2-methoxy benzenesulfonyl)-4-piperazin-1-yl-1H-indole trifluoroacetic acid salt; 5-hydroxytryptamine (serotonin) HT6 receptor antagonists; antidepressant, anxiolytic agent, cognition activator; ADHD, Alzheimer's and Parkinson's disease, drug and nicotine abuse
08/11/2005US20050176701 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
08/11/2005US20050176699 Benzodiazepine derivatives, preparation thereof and use thereof
08/11/2005US20050176698 Neuropeptide Y antagonists
08/11/2005CA2553968A1 Vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain
08/11/2005CA2553089A1 Novel piperidines as chemokine modulators (ccr)
08/11/2005CA2553084A1 Novel benzofuran derivative, medicinal composition containing the same, and uses of these
08/11/2005CA2552558A1 Heterocyclic sulfonamide inhibitors of beta amyloid production containing an azole
08/11/2005CA2552317A1 Hcv ns-3 serine protease inhibitors
08/10/2005EP1561749A1 TNF-Alpha production inhibitors for the treatment of autoimmune diseases
08/10/2005EP1560825A1 Novel 2,3-dihydro-4(1h)-pyridinone derivatives, method for production thereof and pharmaceutical composition comprising the same
08/10/2005EP1560817A1 Methods and compositions of novel triazine compounds
08/10/2005EP1560815A1 Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases
08/10/2005EP1560580A1 Sulfonamides, sulfamates and sulfamides as gamma-secretase inhibitors
08/10/2005EP1392674B1 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors
08/10/2005EP1368340B1 Piperazine derivatives as melanocortin receptor agonists
08/10/2005EP1194425B1 Substituted benzimidazole
08/10/2005CN1653062A (imidazol-1-yl-methyl)-pyridazine as NMDA receptor blocker
08/10/2005CN1653050A Opioid and opioid-like compounds and uses thereof
08/10/2005CN1653048A Pyridine carboxamide derivatives and their use as pesticides
08/10/2005CN1653047A Monocyclic aroylpyridinones as antiinflammatory agents
08/10/2005CN1653046A 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
08/10/2005CN1652779A Treatment of chemokine mediated diseases
08/10/2005CN1652775A Peptide deformylase inhibitors
08/10/2005CN1651430A Synthesis method of saijiabin, its racemate and S-configuration, and preparation method of its amorphous powder
08/10/2005CN1651426A Synthesis method of Gabitril and its racemate and S-configuration
08/10/2005CN1651392A 2-and 2, 5-substituted phenylketoenols
08/10/2005CN1214026C Indol-3-yl derivatives
08/10/2005CN1214017C 四唑衍生物 Tetrazole derivatives
08/10/2005CN1214014C HIV inhibiting pyrimidine derivatives
08/10/2005CN1214007C Cyclopentanoindoles, compositions containing such compounds and methods of treatment
08/09/2005US6927225 Fungicidal 2-pyridyl alkyl amides and their compositions, methods of use and preparation
08/09/2005US6927216 Treatment of inflammatory disorders
08/09/2005CA2105518C Condensed heterocyclic compounds, their production and use
08/04/2005WO2005070920A1 Amino-benzazoles as p2y1 receptor inhibitors
1 ... 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 ... 523